Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Files for Proposed Public Offering of Common Stock

NEW YORK (GenomeWeb) – Twist Bioscience has filed with the US Securities and Exchange Commission for a proposed public offering of 3 million shares of its common stock, the firm said after the close of the market on Monday.

In addition, it will grant the underwriters a 30-day option to purchase an additional 450,000 shares of common stock at the public offering price. Twist has not yet priced the offering.

Twist plans to use the net proceeds to improve and update its platform and technologies. The San Francisco-based synthetic biology company will invest in equipment, expand its next-generation sequencing R&D capabilities, invest in production software, consolidate into a new operation facility, and increase its production capacity, the company said in a statement.

Twist also plans to expand its commercial operations in the US, Europe, and Asia and to expand within the pharmaceutical biologics drug discovery and DNA data storage markets. In addition, the company said it would use the proceeds to establish its NGS operations in China.

JP Morgan Securities, Cowen and Company, and Evercore Group will act as joint book-running managers for the proposed offering with Robert W. Baird & Co. acting as lead manager.

Last week, Twist reported first quarter revenues of $13.6 million, up from $6.2 million during the same period last year. It ended the quarter with $28.7 million in cash and cash equivalents and $75.6 million in short-term investments.

In early Tuesday trade on the Nasdaq, shares of Twist were down 6 percent at $22.84.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.